Tag Archives: Biomarkers

Watch our CEO Robert Thong talk about how we are advancing precision medicine for metabolic-syndrome-related conditions at the LSX Investival Showcase in London.

Read more

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients.

Read more

What insight can recent trials give us into how molecular-level disease drivers can be used to enter into a new era of precision nephrology?

Read more

3/3